How Sennosides Work

Senna is one of the few herbal medicines whose mechanism is understood in enough detail to predict its behaviour rather than just describe it. If you understand one fact — that the molecules you swallow are inactive, and your own gut bacteria are what switch them on — then the six-to-twelve-hour delay, the cramping, the failure after antibiotics, the reason the tea is unpredictable and the reason the colon changes colour after months of use all fall out of it.

This article walks through that chain: sennoside A and B in the leaf, bacterial hydrolysis in the colon, rhein anthrone as the actual active drug, and the two things rhein anthrone does to the bowel. It also covers what the pharmacokinetic studies found about how little of it enters your bloodstream, why standardisation to milligrams of sennoside is the only meaningful label number, and what the mechanism tells you about the side effects before you experience them.

Table of Contents

1. Sennosides A and B: What They Actually Are
2. A Prodrug Switched On by Your Own Bacteria
3. Rhein Anthrone: The Real Active Molecule
4. Two Actions: Motility and Secretion
5. Prostaglandins, Nitric Oxide and Why It Cramps
6. Why Onset Is 6 to 12 Hours
7. Why Antibiotics and Gut Flora Change the Effect
8. What Gets Absorbed, and What Does Not
9. Standardisation: Why “mg of Sennosides” Is the Only Number
10. Leaf, Pod and Species Chemistry
11. What the Mechanism Predicts About Side Effects
12. Key Research Papers
13. Connections

Sennosides A and B: What They Actually Are

Senna leaf and pod contain a family of compounds called anthraquinone glycosides, or anthranoids. The two that matter clinically are sennoside A and sennoside B. Chemically they are close relatives — stereoisomers of one another, differing in the three-dimensional arrangement around a single bond. Minor congeners called sennosides C and D are also present, along with free anthraquinones such as rhein, aloe-emodin and chrysophanol.

Structurally, a sennoside is built from two halves:

• The dianthrone core — two linked anthracene-derived rings, effectively two rhein units joined together. This is where the pharmacological activity ultimately comes from.
• Two glucose molecules attached to that core. These sugars are the reason a sennoside is called a glycoside, and they are the reason it does nothing at all until it reaches the colon.

The sugars change the molecule’s behaviour completely. They make it large, water-loving and poorly absorbed — a molecule that the small intestine essentially cannot take up. That is not an accident of chemistry that pharmacists work around; it is precisely what makes senna a colon-targeted drug.

A useful mental model: a sennoside is an active drug wrapped in a sugar package, with an address label reading “deliver to colon.”

A Prodrug Switched On by Your Own Bacteria

A prodrug is an inactive compound that becomes active only after the body modifies it. Senna is a textbook example — with an unusual twist. Most prodrugs are activated by human enzymes, usually in the liver. Sennosides are activated by bacteria that are not you.

The sequence:

1. Stomach and small intestine. The sennoside passes through largely untouched. Human digestive enzymes cannot efficiently cleave these particular glycosidic bonds, and the molecule is too polar to be absorbed in any meaningful quantity.
2. Arrival in the colon. Here the sennoside meets the dense anaerobic bacterial population of the large bowel — several hundred billion organisms per gram of content.
3. Bacterial β-glucosidase strips off the sugars. This releases sennidin, the dianthrone core.
4. Bacterial reduction. The sennidin is then reduced and split to yield rhein anthrone — the actual active molecule.

This is not a theoretical scheme. Akao and colleagues isolated the specific organism responsible from human intestinal contents in 1994: a strain of Bifidobacterium, designated strain SEN, capable of hydrolysing sennosides to sennidins. Follow-up work by the same group purified the enzyme — a novel sennoside-hydrolysing β-glucosidase — and showed it is inducible, meaning the bacteria make more of it when sennosides are present.

That inducibility is a genuinely interesting detail. It means the bacterial machinery that activates senna can up-regulate with exposure — a real, measured biological adaptation, though not one that has been shown to explain clinical tolerance in humans.

Rhein Anthrone: The Real Active Molecule

Rhein anthrone is where the pharmacology actually happens. It is a small, reactive, fat-soluble molecule generated in situ in the colonic lumen, right against the mucosa it acts on. It is also unstable — readily oxidised to rhein, which is far less active as a laxative.

This creates a self-limiting system with three useful properties:

• It is made where it is needed. No delivery problem to solve.
• It does not travel. Little escapes the colon in active form.
• It degrades quickly. Oxidation to rhein caps the duration of action.

The evidence that rhein anthrone rather than the parent sennoside is the active agent is direct: applying rhein anthrone to isolated intestinal preparations reproduces the laxative pharmacology, while sennosides applied to the same tissue do essentially nothing. Nijs and colleagues demonstrated this in a series of studies on guinea-pig ileum and rat small intestine in the early 1990s.

Two Actions: Motility and Secretion

Rhein anthrone produces a bowel movement by doing two distinct things at once. Both are needed; either alone would be less effective.

1. It stimulates propulsive motility

Rhein anthrone acts on the enteric nervous system — the network of nerves embedded in the bowel wall — and on colonic smooth muscle, increasing the coordinated contractions that propel content forward. In laboratory preparations it enhances the peristaltic reflex: the stereotyped contract-behind, relax-ahead pattern that moves a bolus along. This is the “stimulant” in stimulant laxative.

2. It shifts water and electrolytes into the lumen

Rhein anthrone changes how the colonic epithelium handles water and salt. It inhibits sodium and chloride reabsorption from the lumen and promotes secretion in the opposite direction, so net fluid movement flips from absorption to secretion. More water stays in the colon, and stool that would have been dry and hard is soft and bulky.

Together these produce a softer stool and a colon actively pushing it along. It is also the mechanism behind the two main adverse effects: excessive motility is cramping, and excessive secretion is diarrhoea with fluid and electrolyte loss.

Prostaglandins, Nitric Oxide and Why It Cramps

The intermediate signalling is partly worked out. Several studies by Nijs and colleagues showed that the effects of rhein anthrone on intestinal transit and on secretion could be blunted by inhibitors of prostaglandin synthesis, implying that rhein anthrone triggers local prostaglandin release, which then drives both the motility and the secretory response. Nitric oxide and platelet-activating factor have also been implicated in various preparations.

The prostaglandin link explains something patients notice: senna cramping feels like the crampy, wave-like pain of a gut in overdrive, because that is exactly what it is. Prostaglandin-mediated contraction is the same pathway involved in menstrual cramping.

It also gives a useful practical rule. Cramping is a dose-related, mechanism-linked effect, not an allergy or intolerance. If senna cramps you badly, the fix is usually a lower dose or a divided dose — not abandoning the drug or assuming you react badly to it.

Why Onset Is 6 to 12 Hours

The delay is not a formulation problem that a better tablet could solve. It is the sum of two unavoidable steps:

Anything that changes those steps changes the timing. A stomach full of a large meal slows gastric emptying and pushes onset later. Very slow colonic transit — which is often exactly why someone is constipated — can push it later still, occasionally beyond 12 hours. Rapid transit shortens it.

Two practical conclusions follow. First, judge the dose after a full night, not after four hours. Second, taking a second dose because “it isn’t working” three hours in means both doses will activate together later — the classic route to an unpleasant morning.

Why Antibiotics and Gut Flora Change the Effect

If the drug requires bacteria, then anything that changes the bacteria changes the drug. This is one of the clearest examples of the microbiome acting as a pharmacological organ.

• After broad-spectrum antibiotics, senna can be noticeably less effective while the anaerobic population is depleted. It is a real phenomenon and a reasonable explanation when senna that used to work suddenly does not.
• Between individuals, the amount of sennoside-converting capacity varies. Part of the person-to-person variability in senna response — some people need one tablet, others three — is bacterial, not human.
• The enzyme is inducible, as Yang and colleagues showed, so repeated exposure can increase conversion capacity. Whether this contributes to changing response over time in real patients has not been established in humans.
• Bowel preparation, bowel surgery and severe diarrhoeal illness can all transiently reduce activation.

The same dependency is why senna does not work on the small intestine, and why it does not act as a systemic drug. It is a colon drug because its activator lives in the colon.

What Gets Absorbed, and What Does Not

A common worry is that a laxative “gets into the system.” For senna, the pharmacokinetic answer is reassuring and well measured. Krumbiegel and Schulz studied rhein and aloe-emodin kinetics after senna laxatives in humans and found that only a small fraction of the anthranoid load appears systemically, mostly as rhein — the oxidised, laxative-inactive form — and its conjugates, which are cleared in urine and bile. de Witte’s review of anthranoid metabolism and pharmacokinetics reaches the same conclusion across the class.

Two visible consequences:

• Urine can turn yellow-brown or reddish. This is absorbed anthranoid pigment being excreted. It is harmless and it is not blood. It has been used historically as a marker to detect covert laxative use.
• Breast milk transfer is minimal. Because so little active compound is absorbed, senna is generally regarded as compatible with breastfeeding at normal doses, although occasional loosening of an infant’s stool is reported.

Low systemic absorption is also why senna’s serious risks are almost entirely consequences of what it does in the bowel — fluid and potassium loss — rather than direct organ toxicity. The rare reports of liver injury with senna involve very large, prolonged overdoses, not standard use.

Standardisation: Why “mg of Sennosides” Is the Only Number

Sennoside content in raw senna leaf varies with variety, growing conditions, harvest timing, drying and storage. Two batches of the same-looking dried leaf can differ several-fold in potency. This is the general problem with botanical dosing — and senna is one of the few herbs where it has been solved.

Pharmacopoeial senna is assayed and expressed as hydroxyanthracene glycosides calculated as sennoside B. Finished products are formulated to a stated sennoside content: 8.6 mg, 15 mg, 25 mg per tablet. That number is comparable across brands and comparable to the doses used in trials.

This table is the single most practical takeaway of the whole mechanism. If you cannot find a sennoside figure, you are guessing at your dose. That is a nuisance with a pharmacy tablet and a genuine hazard with a slimming tea, which is covered in Senna in Weight-Loss and Detox Teas.

Leaf, Pod and Species Chemistry

Both parts of the plant are official medicines with their own pharmacopoeial monographs.

• Senna leaf (Sennae folium) generally carries a higher sennoside concentration and is traditionally regarded as harsher, with more cramping per unit of effect.
• Senna pod (Sennae fructus) is regarded as gentler and better tolerated. European preparations often favour pod. Alexandrian and Tinnevelly pods have slightly different required sennoside minima.

Once a product is standardised to sennoside content, the practical difference narrows — you are dosing the active compound either way — but the accessory anthranoids differ, and tolerability reports still favour pod.

The genus context matters too. Anthraquinones are widespread in Senna, Rheum (rhubarb), Rhamnus (cascara and buckthorn) and Aloe. Cascara and aloe latex work through the same bacterially-activated anthranoid mechanism as senna, which is why they share its side-effect profile and its melanosis coli. It is also why “natural colon cleanse” blends stacking senna with cascara and aloe deliver a much larger anthranoid dose than any single-ingredient product — while looking, on the label, like a gentle herbal tea.

And a species that shares the chemistry but not the use: Senna alata, the ringworm bush, is a different plant used topically as an antifungal. Same genus, same anthraquinone family, completely different application. Do not read information about one as information about the other.

What the Mechanism Predicts About Side Effects

Because the mechanism is well characterised, the adverse effects are predictable rather than mysterious. Every item below follows directly from something above.

The one thing the mechanism does not straightforwardly predict is permanent damage to the enteric nerves. That question — the “cathartic colon” argument — remains genuinely contested, and is treated in detail in the next article.

Key Research Papers

Every identifier was checked live against NCBI E-utilities before being written — author, title, journal and year all had to match.

Bacterial activation of sennosides

1. Akao T, Che QM, Kobashi K, Yang L, Hattori M, Namba T. Isolation of a human intestinal anaerobe, Bifidobacterium sp. strain SEN, capable of hydrolyzing sennosides to sennidins. Applied and Environmental Microbiology. 1994;60(3):1041–1043. Bacteriology — identified the activating organism from human gut contents.
2. Yang L, Akao T, Kobashi K, Hattori M. Purification and characterization of a novel sennoside-hydrolyzing β-glucosidase from Bifidobacterium sp. strain SEN, a human intestinal anaerobe. Biological & Pharmaceutical Bulletin. 1996;19(5):705–709. Enzyme purification.
3. Yang L, Akao T, Kobashi K, Hattori M. A sennoside-hydrolyzing β-glucosidase from Bifidobacterium sp. strain SEN is inducible. Biological & Pharmaceutical Bulletin. 1996;19(5):701–704.

Rhein anthrone pharmacology

1. Nijs G, de Witte P, Geboes K, Meulemans A, Schuurkes J, Lemli J. Influence of rhein anthrone on peristaltic reflex of guinea-pig isolated ileum: involvement of prostaglandins. British Journal of Pharmacology. 1993;108(1):269–273. Isolated-tissue study.
2. Nijs G, de Witte P, Geboes K, Lemli J. Influence of rhein anthrone and rhein on small intestine transit rate in rats: evidence of prostaglandin mediation. European Journal of Pharmacology. 1992;218(2–3):199–203. Animal study.
3. Nijs G, de Witte P, Van Hoestenberghe A, Geboes K, Lemli J. Direct and indirect evidence for the involvement of prostaglandins in the secretagogue action of rhein anthrone in the small intestine. Acta Gastro-Enterologica Belgica. 1991;54(2):184–190. Animal study.
4. Lemli J. [The mechanism of action of sennosides]. Annales de Gastroentérologie et d’Hépatologie. 1996;32(2):109–112. Review, in French.

Metabolism, kinetics and mucosal effects

1. de Witte P. Metabolism and pharmacokinetics of anthranoids. Pharmacology. 1993;47(Suppl 1):86–97. Review of the whole activation and elimination pathway.
2. Krumbiegel G, Schulz HU. Rhein and aloe-emodin kinetics from senna laxatives in man. Pharmacology. 1993;47(Suppl 1):120–124. Human pharmacokinetic study — showed how little enters the circulation.
3. Geboes K, Spiessens C, Nijs G, de Witte P. Anthranoids and the mucosal immune system of the colon. Pharmacology. 1993;47(Suppl 1):49–57.
4. Walker NI, Bennett RE, Axelsen RA. Melanosis coli: a consequence of anthraquinone-induced apoptosis of colonic epithelial cells. The American Journal of Pathology. 1988;131(3):465–476. Explains the pigmentation mechanistically.

Chemistry and analysis

1. Park SB, Kim YS. Simultaneous separation of three isomeric sennosides from senna leaf (Cassia acutifolia) using counter-current chromatography. Journal of Separation Science. 2015;38(20):3502–3507. Analytical chemistry of the sennoside isomers.
2. Sennoside content variation, pharmacopoeial assay methods and standardisation of senna preparations. PubMed topic search — no single citation confirmed, so a search is given rather than a possibly wrong identifier.

Live PubMed Searches

1. Sennoside A and sennoside B
2. Rhein anthrone and the colon
3. Anthraquinone glycoside activation by gut microbiota
4. Stimulant laxative mechanism of action
5. Colonic secretion and prostaglandins
6. Bacterial β-glucosidase and glycoside hydrolysis
7. Rhein pharmacokinetics in humans
8. Senna leaf and senna pod monographs

Connections

• All Herbs
• Senna Benefits — hub
• Constipation: Short-Term Use — dose and timing
• Dependence, Melanosis Coli and Long-Term Risk
• Senna in Weight-Loss and Detox Teas
• Senna — main topic page
• Cassia alata (Ringworm Bush) — same genus, topical antifungal use
• Potassium — what the secretory action costs you
• Gastroenterology
• Constipation
• Slippery Elm — mucilage, not stimulation
• Marshmallow Root

Back to Table of Contents